Patent · US Active

Diagnostic and therapeutic epitope, and transgenic plant

US7888460B2 · kind B2 · utility

30Cited by
44References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2006
Grant dateFeb 15, 2011
Priority date—
Expiry dateNov 27, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A food comprising a mutant gliadin protein that comprises at least one mutation in the epitope 62PQPQLPY68 (SEQ ID NO:6), wherein the mutation decreases the ability of the epitope to induce a T cell response, or a fragment of the mutant gliadin protein wherein the fragment is at least 15 amino acids long and comprises the mutated 62PQPQLPY68 (SEQ ID NO:6) is provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.